ATE453634T1 - Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen - Google Patents
Regioselektives verfahren zur zubereitung von benzimidazol-thiophenenInfo
- Publication number
- ATE453634T1 ATE453634T1 AT06813938T AT06813938T ATE453634T1 AT E453634 T1 ATE453634 T1 AT E453634T1 AT 06813938 T AT06813938 T AT 06813938T AT 06813938 T AT06813938 T AT 06813938T AT E453634 T1 ATE453634 T1 AT E453634T1
- Authority
- AT
- Austria
- Prior art keywords
- thiophenes
- preparing benzimidazole
- regioselective process
- preparing
- benzimidazole
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 title 1
- 229930192474 thiophene Natural products 0.000 title 1
- OHNAITIAQLQHJY-UHFFFAOYSA-N 1h-benzimidazole;thiophene Chemical class C=1C=CSC=1.C1=CC=C2NC=NC2=C1 OHNAITIAQLQHJY-UHFFFAOYSA-N 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71430105P | 2005-09-06 | 2005-09-06 | |
| PCT/US2006/033793 WO2007030366A1 (en) | 2005-09-06 | 2006-08-28 | Regioselective process for preparing benzimidazole thiophenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE453634T1 true ATE453634T1 (de) | 2010-01-15 |
Family
ID=37605702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06813938T ATE453634T1 (de) | 2005-09-06 | 2006-08-28 | Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20080249301A1 (de) |
| EP (1) | EP1924572B1 (de) |
| JP (1) | JP2009507022A (de) |
| KR (1) | KR20080045266A (de) |
| CN (1) | CN101304986A (de) |
| AT (1) | ATE453634T1 (de) |
| AU (1) | AU2006287771A1 (de) |
| BR (1) | BRPI0615705A2 (de) |
| CA (1) | CA2621073A1 (de) |
| DE (1) | DE602006011482D1 (de) |
| EA (1) | EA200800549A1 (de) |
| ES (1) | ES2338590T3 (de) |
| IL (1) | IL189769A0 (de) |
| MA (1) | MA29781B1 (de) |
| MX (1) | MX2008003172A (de) |
| NO (1) | NO20081101L (de) |
| WO (1) | WO2007030366A1 (de) |
| ZA (1) | ZA200801950B (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE459620T1 (de) * | 2005-09-06 | 2010-03-15 | Glaxosmithkline Llc | Benzimidazolthiophenverbindungen als plk- modulatoren |
| AR055616A1 (es) * | 2005-09-06 | 2007-08-29 | Smithkline Beecham Corp | Compuestos de tiofeno bencimidazol |
| JP5498703B2 (ja) | 2006-01-23 | 2014-05-21 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なチオフェン−カルボキサミド |
| EP2418210A1 (de) | 2006-04-13 | 2012-02-15 | Vertex Pharmceuticals Incorporated | Als Protein-Kinase-Inhibitoren nutzbare Thiophen-Carboxamide |
| JP2009538309A (ja) | 2006-05-23 | 2009-11-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド |
| WO2007139795A1 (en) | 2006-05-23 | 2007-12-06 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
| US7615643B2 (en) | 2006-06-02 | 2009-11-10 | Smithkline Beecham Corporation | Benzimidazole thiophene compounds |
| US8236954B2 (en) * | 2007-06-26 | 2012-08-07 | Glaxosmithkline Llc | Processes for preparing benzimidazole thiophenes |
| EP2100894A1 (de) | 2008-03-12 | 2009-09-16 | 4Sc Ag | Pyridopyrimidinone verwendbar als Plk1 (polo-like kinase) Hemmen |
| EP2558437B1 (de) | 2010-04-12 | 2015-08-05 | Supernus Pharmaceuticals, Inc. | Verfahren zur herstellung von viloxazinsalzen und neue polymorphe daraus |
| EP2588107A1 (de) | 2010-07-01 | 2013-05-08 | Takeda Pharmaceutical Company Limited | Kombination aus einem cmet-hemmer und einem antikörper gegen hgf und/oder cmet |
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| EP2565186A1 (de) | 2011-09-02 | 2013-03-06 | Hybrigenics S.A. | Spezifische und reversible Inhibitoren von ubiquitinspezifischer Protease 7 |
| RU2014144951A (ru) | 2012-04-10 | 2016-06-10 | Сумитомо Дайниппон Фарма Ко., Лтд. | Новое 1-замещенное производное индазола |
| US9611267B2 (en) | 2012-06-13 | 2017-04-04 | Incyte Holdings Corporation | Substituted tricyclic compounds as FGFR inhibitors |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| TWI649318B (zh) | 2013-04-19 | 2019-02-01 | 英塞特控股公司 | 作為ｆｇｆｒ抑制劑之雙環雜環 |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| AU2016219822B2 (en) | 2015-02-20 | 2020-07-09 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| MX2020006587A (es) | 2017-12-22 | 2020-12-10 | Ravenna Pharmaceuticals Inc | Derivados de aminopiridina como inhibidores de fosfatidilinositol fosfato cinasa. |
| ES2991427T3 (es) | 2018-05-04 | 2024-12-03 | Incyte Corp | Formas sólidas de un inhibidor de FGFR y procedimientos para preparar las mismas |
| TW201946630A (zh) | 2018-05-04 | 2019-12-16 | 美商英塞特公司 | Fgfr抑制劑之鹽 |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| CN109988098A (zh) * | 2019-05-23 | 2019-07-09 | 常州工程职业技术学院 | 一种(r)-n-叔丁氧羰基-3-羟甲基哌啶的合成方法 |
| TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
| WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| WO2021067374A1 (en) | 2019-10-01 | 2021-04-08 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| GEAP202415945A (en) | 2019-10-14 | 2024-04-25 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| CA3163875A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| AU2020395185A1 (en) | 2019-12-04 | 2022-06-02 | Incyte Corporation | Derivatives of an FGFR inhibitor |
| WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| EP4323405A1 (de) | 2021-04-12 | 2024-02-21 | Incyte Corporation | Kombinationstherapie mit einem fgfr-inhibitor und einem auf nectin-4 abzielenden mittel |
| CA3220274A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| AR126101A1 (es) | 2021-06-09 | 2023-09-13 | Incyte Corp | Heterociclos tricíclicos como inhibidores de fgfr |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5990146A (en) * | 1997-08-20 | 1999-11-23 | Warner-Lambert Company | Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation |
| US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| GB0005642D0 (en) * | 2000-03-10 | 2000-05-03 | Astrazeneca Uk Ltd | Chemical compounds |
| WO2003037890A2 (en) * | 2001-11-01 | 2003-05-08 | Icagen, Inc. | Piperidines |
| BR0313160A (pt) * | 2002-08-08 | 2005-07-12 | Smithkline Beecham Corp | Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto |
| US7491737B2 (en) * | 2002-10-30 | 2009-02-17 | Merck & Co., Inc. | Heterarylpiperidine modulators of chemokine receptor activity |
| WO2005037827A1 (en) * | 2003-10-16 | 2005-04-28 | Smithkline Beecham Corporation | Process for preparing benzimidazole thiophenes |
-
2006
- 2006-08-28 EP EP06813938A patent/EP1924572B1/de active Active
- 2006-08-28 CN CNA2006800413629A patent/CN101304986A/zh active Pending
- 2006-08-28 JP JP2008529214A patent/JP2009507022A/ja not_active Ceased
- 2006-08-28 EA EA200800549A patent/EA200800549A1/ru unknown
- 2006-08-28 ES ES06813938T patent/ES2338590T3/es active Active
- 2006-08-28 MX MX2008003172A patent/MX2008003172A/es not_active Application Discontinuation
- 2006-08-28 AU AU2006287771A patent/AU2006287771A1/en not_active Abandoned
- 2006-08-28 WO PCT/US2006/033793 patent/WO2007030366A1/en not_active Ceased
- 2006-08-28 BR BRPI0615705A patent/BRPI0615705A2/pt not_active IP Right Cessation
- 2006-08-28 KR KR1020087008167A patent/KR20080045266A/ko not_active Withdrawn
- 2006-08-28 DE DE602006011482T patent/DE602006011482D1/de active Active
- 2006-08-28 US US12/065,655 patent/US20080249301A1/en not_active Abandoned
- 2006-08-28 CA CA002621073A patent/CA2621073A1/en not_active Abandoned
- 2006-08-28 AT AT06813938T patent/ATE453634T1/de not_active IP Right Cessation
-
2008
- 2008-02-26 IL IL189769A patent/IL189769A0/en unknown
- 2008-02-29 ZA ZA200801950A patent/ZA200801950B/xx unknown
- 2008-03-03 NO NO20081101A patent/NO20081101L/no not_active Application Discontinuation
- 2008-03-17 MA MA30750A patent/MA29781B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008003172A (es) | 2008-03-18 |
| CA2621073A1 (en) | 2007-03-15 |
| EP1924572B1 (de) | 2009-12-30 |
| IL189769A0 (en) | 2008-08-07 |
| JP2009507022A (ja) | 2009-02-19 |
| EP1924572A1 (de) | 2008-05-28 |
| AU2006287771A1 (en) | 2007-03-15 |
| US20080249301A1 (en) | 2008-10-09 |
| EA200800549A1 (ru) | 2008-08-29 |
| ZA200801950B (en) | 2009-09-30 |
| DE602006011482D1 (de) | 2010-02-11 |
| CN101304986A (zh) | 2008-11-12 |
| KR20080045266A (ko) | 2008-05-22 |
| NO20081101L (no) | 2008-04-04 |
| WO2007030366A1 (en) | 2007-03-15 |
| BRPI0615705A2 (pt) | 2016-08-23 |
| ES2338590T3 (es) | 2010-05-10 |
| MA29781B1 (fr) | 2008-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE453634T1 (de) | Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen | |
| EP2038375A4 (de) | Verfahren zur herstellung von grundölen | |
| UY33981A (es) | ?método para preparar compuestos macrocíclicos inhibidores de serina proteasas de hepatitis c?. | |
| CY1110010T1 (el) | Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4) | |
| EA201001359A1 (ru) | Гетероциклические соединения в качестве ингибиторов cxcr2 | |
| DE502006001614D1 (de) | Verfahren zur herstellung von 1-alkyl-3-phenyluracilen | |
| DE602007013512D1 (de) | Verfahren zur kontinuierlichen Herstellung von Bauteilen | |
| ATE522518T1 (de) | Indazol- und isoindolderivate als glucokinaseaktivierende stoffe | |
| EA200900945A1 (ru) | Новый способ синтеза агомелатина | |
| DE602005015174D1 (de) | Verfahren zur herstellung von montelukast-natrium | |
| CY1118173T1 (el) | 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων | |
| EA200900946A1 (ru) | Новый способ синтеза агомелатина | |
| ATE485279T1 (de) | Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden | |
| CY1112520T1 (el) | Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες | |
| DE602006014670D1 (de) | Verfahren zur doppelbindungs-hydroisomerisierung von butenen | |
| DE502005004141D1 (de) | Verfahren zur kompensation von thermischen verlagerungen | |
| ATE519722T1 (de) | Verfahren zur palladiumkatalysierten kopplung von terminalalkynen mit aryltosylaten | |
| DE502007003531D1 (de) | Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten | |
| EP2259269A4 (de) | Verfahren zur herstellung von radiostrontium | |
| DE502007000339D1 (de) | Verfahren zur Herstellung von Urethangruppen aufweisenden Organosiliciumverbindungen | |
| DE112009000076A5 (de) | Verfahren zur Herstellung von Urethanen | |
| EA200900943A1 (ru) | Новый способ синтеза агомелатина | |
| DE502007000718D1 (de) | Verfahren zur Herstellung von Carbidkeramik-Bauteilen | |
| DE602004014264D1 (de) | Verfahren zur herstellung von olanzapin | |
| DE502005007702D1 (de) | Verfahren zur herstellung von terrylen-3,4:11,12-t |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |